| CAS NO: | 848057-98-7 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 生物活性 | SPHINX is a selectiveSRPK1inhibitor with anIC50value of 0.58 μM. SPHINX effectively reduces Choroidal Neovascularization (CNV) in vivo. SPHINX can be used for the research of (age-related macular degenaration) AMD[1]. | ||||||||||||||||
| IC50& Target | IC50: 0.58 μM (SRPK1)[1] | ||||||||||||||||
| 体外研究 (In Vitro) | SPHINX (10 μM; 2 h) affects EGF-induced phosphorylation of SRSF1 and SRSF2[1].SPHINX (5 μM; 24 h) reduces the expression of VEGF165 relative to GAPDH control either in primary RPE and ARPE-19 cell lines[1]. Western Blot Analysis[1]
| ||||||||||||||||
| 体内研究 (In Vivo) | SPHINX (10 ng; i.o. on laser photocoagulation day 0 and day 7) affects neovascular growth in vivo[1].SPHINX (25 ng; i.o. on laser photocoagulation day 0 and day 7) affects the CNV area in CNV rats[1].
| ||||||||||||||||
| Clinical Trial | |||||||||||||||||
| 分子量 | 354.32 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C17H17F3N2O3 | ||||||||||||||||
| CAS 号 | 848057-98-7 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 50 mg/mL(141.12 mM;ultrasonic and warming and heat to 60℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
